Snowball logo
logo
MLYS

Mineralys Therapeutics Inc. Common Stock

MLYS โ€ข NASDAQ
$30.56+$0.14ย  (0.46%)

Frequently asked questions

What sector does Mineralys Therapeutics Inc. Common Stock (MLYS) operate in?

Mineralys Therapeutics Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Mineralys Therapeutics Inc. Common Stock (MLYS) current stock price?

As of the latest data, Mineralys Therapeutics Inc. Common Stock stock price is $30.56, with a previous close of $30.42. Mineralys Therapeutics Inc. Common Stock gained $0.14 in the last trading session, representing a 0.46% increase.

What is Mineralys Therapeutics Inc. Common Stock (MLYS) current market capitalization?

Mineralys Therapeutics Inc. Common Stock market cap is approximately 2.52 billion.

What is Mineralys Therapeutics Inc. Common Stock (MLYS) Earnings Per Share (EPS)?

The trailing EPS is -$2.29, and the forward EPS is -$1.83.

What is Mineralys Therapeutics Inc. Common Stock (MLYS) EBITDA?

Mineralys Therapeutics Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -38.27 million.

Does Mineralys Therapeutics Inc. Common Stock (MLYS) pay dividends?

No. Mineralys Therapeutics Inc. Common Stock does not pay a dividend.

When is Mineralys Therapeutics Inc. Common Stock (MLYS) next earnings report?

Mineralys Therapeutics Inc. Common Stock is expected to release its next earnings report on March 31, 2026.

What is Mineralys Therapeutics Inc. Common Stock (MLYS) beta (volatility) score?

Mineralys Therapeutics Inc. Common Stock has a beta of 0.567, indicating lower volatility than the overall market.